AR-Based Motor Rehabilitation for Children With CP (PSYCHO-AR-REH)
25. juni 2026 oppdatert av: Rudolf Psotta, College of Physical Education and Sport PALESTRA
Digitalization of Rehabilitation Care for Children With Motor Disorders Using Augmented Reality Technologies
The aim of the project is to create a digital system for cognitive-oriented rehabilitation of the central neuromuscular diseases (CND) with the use of augmented reality (AR) technology in children.
Solving the project supports the professional-oriented digital literacy of professionals in rehabilitation institutions in the Czech Republic (CR).
With the applied research, the software will be developed for the training of fine and gross motor skills, postural control and walking in the AR environment for children with cerebral palsy and verified in the practice of professionals in rehabilitation.
The project aims to modernization and increase of the effectiveness of the work of professionals in rehabilitation institutions in the CR.
The project is based on an interdisciplinary approach.
Studieoversikt
Status
Påmelding etter invitasjon
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Antatt)
40
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Prague, Tsjekkia
- Palestra
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Medical diagnosis of spastic hemiparesis or diparesis types cerebral palsy
- The level of motor skills was at levels I and II according to the Gross Motor Function Classification System (GMFCS)
- spasticity of grade 2 or less diagnosed with the Modified Ashworth Scale (MAS)
- Ability to walk at least 10 meters without aids and without the support of a therapist
Exclusion Criteria:
- no neurological disease other than CP
- no visual impairment with exception of short-sightedness
- Children is not able to follow instructions during testing and training
- Injection treatment of anti-spastic medication in the last 3 months
- Lower limb surgery within the past 12 months
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Eksperimentell gruppe
|
Traditional spa treatment comprising hydrotherapy and physical therapy.
The child wore Meta Quest 3 (Meta Platforms, Menlo Park, California, USA) VR/AR goggles during the exercises.
Our custom exercise applications were running on the device.
They provide brief verbal instructions at the start of each exercise.
During the exercise, they also give short cognitive prompts to support focused attention.
|
|
Aktiv komparator: Control group
conventional physical therapy program
|
Traditional spa treatment comprising hydrotherapy and physical therapy.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Speed of 10-meter walk test (m/s)
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
Speed (m/s): average speed of the walk 10 metres (10MWT)
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
|
Cadence (steps/min)
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
Number of half-steps in one minute.
Data will be analyzed with the G-Studio software (BTS G-Walk, BTS Bioengineering)
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
|
Support phase (% cycle)
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
The average value of the durations of the right and left support phases as percentages of the duration of the gait cycle.
Data will be analyzed with the G-Studio software (BTS G-Walk, BTS Bioengineering).
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
|
Swing Phase (% Cycle)
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
The average value of the durations of the right and left swing phases as percentages of the duration of the gait cycle.
Data will be analyzed with the G-Studio software (BTS G-Walk, BTS Bioengineering).
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
|
Symmetry index of pelvic tilt
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
The movements of the pelvis in the three principal planes are evaluated using symmetry indexes between the right and left gait cycle.
Non-pathological subjects show an index greater than 90.
The pelvic tilt, is the sagittal component of 3D pelvic movement.
Data will be analyzed with the G-Studio software (BTS G-Walk, BTS Bioengineering).
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
|
Symmetry index of pelvic obliquity
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
The movements of the pelvis in the three principal planes are evaluated using symmetry indexes between the right and left gait cycle.
Non-pathological subjects show an index greater than 90.
The pelvic tilt, is the frontal component of 3D pelvic movement.
Data will be analyzed with the G-Studio software (BTS G-Walk, BTS Bioengineering).
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
|
Symmetry index of pelvic rotation
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
The movements of the pelvis in the three principal planes are evaluated using symmetry indexes between the right and left gait cycle.
Non-pathological subjects show an index greater than 90.
The pelvic tilt, is the transverse component of 3D pelvic movement.
Data will be analyzed with the G-Studio software (BTS G-Walk, BTS Bioengineering).
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
|
The Pediatric balance scale (PBS)
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
The Pediatric Balance Scale is a modified version of the Berg Balance Scale.
The scale consists of 14 balance-related test items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points.
Higher total scores suggest that the child has good balance ability.
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
One-Leg Balance (valuated by the time the child is able to maintain the position)
Tidsramme: Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
In this task, the child is asked to stand on one leg on a balance board or other unstable surface.
Each leg is tested separately.
The child must maintain balance for a maximum of 30 seconds.
The task is assessed in accordance with the MABC-2 manual.
|
Change from pre-intervention (first day) to post-intervention (last day of 4-week motor training program)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Samarbeidspartnere
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. mars 2025
Primær fullføring (Antatt)
1. august 2026
Studiet fullført (Antatt)
1. august 2026
Datoer for studieregistrering
Først innsendt
11. mars 2026
Først innsendt som oppfylte QC-kriteriene
17. juni 2026
Først lagt ut (Faktiske)
24. juni 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
30. juni 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
25. juni 2026
Sist bekreftet
1. juni 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- TQ01000031
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .